The Pfizer logo, used by an American biopharmaceutical company, consists of a graphic symbol and the brand name. The symbol is formed by two broad curved ribbons that wrap around a common center and meet at their edges in the middle of the composition, creating a three-dimensional twisted form. The main color version uses light and dark blue, with the outer and inner sides of each ribbon rendered in different shades to emphasize their curves and interwoven structure. The design is based on the image of a DNA double helix and was created by reworking Pfizer’s previous oval logo, which resembled a pill. In the single-color version, the entire logo is rendered in one shade of blue, while cutouts at the ribbon folds visually separate their surfaces and preserve the sense of depth without using a second color. To the right of the symbol is the Pfizer name in its custom blue lettering, with the lowercase letters f and i joined into a single typographic composition. The current identity was introduced in January 2021 and marked the first major change to Pfizer’s corporate symbol in around 70 years. The shift from the former oval shape to the double helix reflected Pfizer’s stronger emphasis on scientific research and the development of new medicines. The name Pfizer comes from the surname of one of the company’s founders, Charles Pfizer.
Pfizer Inc. is an American biopharmaceutical company founded in 1849 in Brooklyn, New York, by cousins Charles Pfizer and Charles Erhart. The company’s first product was the antiparasitic drug santonin, and Pfizer later played a significant role in the development of mass penicillin production, eventually becoming one of the world’s largest developers of medicines and vaccines. Today, the company researches, develops and manufactures biopharmaceutical products, operates in approximately 200 countries and territories, has 36 manufacturing sites and employs around 75,000 people. Pfizer’s global headquarters is located in New York City.
